About the Blood and Marrow Transplant Network
The Blood and Marrow Transplant (BMT) Network was established to support collaboration, the sharing of lessons learned and networking of BMT clinicians in NSW public hospitals. The Network provides governance to statewide clinical improvement initiatives; delivers a statewide quality management service; and provides centralised education events. The BMT Network Council provides oversight to Network activities and directs the work of its clinical working groups and project sub-committees. The BMT Quality Management Service assists BMT programs to meet and maintain their accreditation requirements and provides policies, standard operating procedures, onsite training and support.
John Kwan, Co-Chair
Western Sydney Local Health District
Annette Trickett, Co-Chair
NSW Health Pathology
Prince of Wales Hospital, Randwick
South Eastern Sydney Local Health District
The network has more than 290 registered members across NSW, Australia and internationally.
The ACI BMT Network has been active since 2002. The network now encompasses the 16 NSW hospitals involved in these transplants. The network continues to be a clinician-led enterprise which has facilitated many new initiatives.
Transplantation of blood and marrow products is provided as treatment for patients suffering from haematological and auto immune disorders as well as certain solid tissue tumours.
Transplantation can be either autologous (where the patient has previously donated their own haematopoietic progenitor stem cells or bone marrow), or allogeneic (where the donor is a tissue-matched related or unrelated donor). More than 300 autologous and 200 allogeneic transplants are carried out in NSW each year.